The role of p38 MAPK in gastrin-induced u-PA expression in human colon cancer cells.
- Author:
	        		
		        		
		        		
			        		Mei MING
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Jie-ping YU
			        		
			        		;
		        		
		        		
		        		
			        		Yan-hong ZHOU
			        		
			        		;
		        		
		        		
		        		
			        		Jun CAO
			        		
			        		;
		        		
		        		
		        		
			        		Wen-chong SONG
			        		
			        		;
		        		
		        		
		        		
			        		Hong-gang YU
			        		
			        		;
		        		
		        		
		        		
			        		He-sheng LUO
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Journal Article
 - MeSH: Benzodiazepinones; pharmacology; Blotting, Western; Cell Line, Tumor; Colonic Neoplasms; genetics; metabolism; pathology; Gastrins; pharmacology; Gene Expression Regulation, Neoplastic; drug effects; Genetic Vectors; Humans; Imidazoles; pharmacology; Phenylurea Compounds; pharmacology; Phosphorylation; drug effects; Pyridines; pharmacology; RNA, Messenger; biosynthesis; genetics; Receptor, Cholecystokinin B; genetics; metabolism; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; drug effects; Transfection; Urokinase-Type Plasminogen Activator; genetics; metabolism; p38 Mitogen-Activated Protein Kinases; metabolism
 - From: Chinese Journal of Oncology 2007;29(1):4-8
 - CountryChina
 - Language:Chinese
 - 
		        	Abstract:
			       	
			       		
				        
				        	
OBJECTIVETo study the effect of gastrin on the mRNA and protein expression of urokinase-type plasminogen activator (u-PA) in human colon cancer cells and detect the role of p38 MAPK in this process.
METHODSLipofectin method was used to transfect pCR3. 1/CCK2R vector expressing gastrin receptor into a colon cancer cell line colo320. Gastrin and gastrin antagonist were used to up-regulate and down-regulate the signaling pathway, respectively. Human colon cancer colo320 cells and colo320/ CCK2,R cells were cultured and then stimulated with gastrin for different time; SB203580 was added into culture medium to prevent p38 kinase pathway before incubating with gastrin; Western blot and RT-PCR were used to examine the u-PA expression. Western blot was employed to detect p38 kinase phosphorylation.
RESULTSGastrin increased evidently the mRNA and protein expressions of u-PA and induced p38 kinase phosphorylation in colo320/CCK,R cells time-dependently. However, the extent of enhancement of u-PA and p38 MAPK expression in colo320 cells was much less than that in colo320/CCK2R cells. The gastrin antagonist L-365, 260 showed an effect of competitive inhibition on gastrin-induced u-PA expression and p38 kinase phosphorylation. The inhibitor SB203580 could sufficiently suppress gastrin-induced p38 kinase phosphorylation and significantly attenuate gastrin-induced u-PA mRNA and protein expressions in colo320/ CCK2 R cells in a dose-dependent manner.
CONCLUSIONGastrin-gastrin receptor signal transduction pathway can obviously induce u-PA expression in human colon cancer cells via activating the phosphorylation of p38 kinase.
 
            